Hair loss researchers have in recent years published a few studies related to the link between fat cells (adipocytes) and hair cells. It is well documented that balding men have tighter and thinner fat depleted scalps. Many doctors are injecting adipose-derived stem cells into scalps in order to regrow hair.
Epidermal Wnt/β-catenin Signaling Regulates Adipocyte Differentiation
In the latest findings, a new research paper (co-authored by Dr. Fiona Watt of King’s College and Dr. Rodney Sinclair of University of Melbourne) concludes that epidermal Wnt/β-catenin is a critical initiator of a signaling cascade. This in turn induces adipogenesis. The paper’s main conclusion:
“Epidermal Wnt/β-catenin as a critical initiator of a signaling cascade that induces adipogenesis and highlight the role of epidermal Wnt signaling in synchronizing adipocyte differentiation with the hair growth cycle.”
Fat Dissolving Cream

Apparently, the implications of the above work are that a fat dissolving cream could soon be invented. The protein that activates hair follicle growth has been shown to also inhibit fat production.
Of course most of us are interested in the hair loss aspect of this research and not too concerned about the fat cells link. However, excessive fat/obesity is now becoming as common as baldness in men. And obesity is far more common than baldness in women. Many obese people do not eat too much and are not lazy as usually depicted in the media.
Rather, their genetics and hormonal makeup often makes it close to impossible for them to loose and keep too much weight off. Even with their best effort to exercise and limit caloric intake daily, some people will always be 50 pounds overweight.
It is therefore not surprising that the same pathways examined in prior hair loss related research are now being examined in order to potentially develop a blockbuster fat dissolving cream.
Unfortunately, even if developed, such a cream would not aid in reducing the more dangerous excessive visceral fat around our essential organs. The fat that would be reduced is the less dangerous subcutaneous fat, which is cosmetically distressing for a lot of people.
Update: 2025 — The massive boom in new GLP-1 drugs has now changed this discussion. Around one in eight Americans now takes these drugs for weight loss or to treat diabetes. The most popular ones are: Ozempic and Wegovy (both containing semaglutide); and Mounjaro and Zepbound (both containing tirzepatide).
